| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
MNMD (MNMD) has 9 insiders with recent SEC Form 4 filings, including 1 buy and 9 sells. MNMD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 778.5K | $10.23M | - | |
| CFO | 500.0K | - | - | |
| Other | 425.0K | $5.59M | - | |
| Other | 282.6K | $3.71M | - | |
| Dir | 75.2K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 25, 2025 | Karlin Daniel | Chief Medical Officer | Sell | 6,836 | $6.74 | $46,074.64 | -1.5% | |
| Mar 25, 2025 | Sullivan Mark | Chief Legal Officer | Sell | 6,576 | $6.74 | $44,322.24 | -2.0% | |
| Mar 25, 2025 | Liao Carrie | Chief Accounting Officer | Sell | 2,347 | $6.74 | $15,818.78 | -1.6% | |
| Dec 26, 2024 | Barrow Robert | Chief Executive Officer | Sell | 19,106 | $7.43 | $141,957.58 | -3.5% | |
| Dec 26, 2024 | Liao Carrie | Chief Accounting Officer | Sell | 2,273 | $7.43 | $16,888.39 | -2.3% | |
| Dec 26, 2024 | Karlin Dan | Chief Medical Officer | Sell | 6,643 | $7.43 | $49,357.49 | -1.9% | |
| Dec 26, 2024 | Sullivan Mark | Chief Legal Officer | Sell | 4,519 | $7.43 | $33,576.17 | -2.5% | |
| Dec 5, 2024 | Gryska David W | Director | Buy | 2,500 | $7.17 | $17,925.00 | +14.4% | |
| Sep 25, 2024 | Liao Carrie | Chief Accounting Officer | Sell | 2,352 | $5.98 | $14,064.96 | -2.3% | |
| Sep 25, 2024 | Barrow Robert | Chief Executive Officer | Sell | 19,771 | $5.98 | $118,230.58 | -3.5% |